| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Current Issue > Browse Articles > Current Issue



Editorial
141 Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
Tae Hyun Kim
Radiat Oncol J. 2023;41(3):141-143.   Published online 2023 Sep 12     DOI: https://doi.org/10.3857/roj.2023.00710
                        
Review Article
144 Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Byoung Hyuck Kim, Jae Sik Kim, Hak Jae Kim
Radiat Oncol J. 2023;41(3):144-153.   Published online 2023 Aug 23     DOI: https://doi.org/10.3857/roj.2023.00430
                        
Original Articles
154 Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer
Heidi M. Vieira, David P. Kasper, Runqiu Wang, Lynette M. Smith, Charles A. Enke, Raymond C. Bergan, Benjamin A. Teply, Michael J. Baine
Radiat Oncol J. 2023;41(3):154-162.   Published online 2023 Sep 21     DOI: https://doi.org/10.3857/roj.2023.00262
                        Supplementary      
roj-2023-00262f1.jpgroj-2023-00262f2.jpg
163 Clinical outcomes of radical radiotherapy for pulmonary sarcomatoid carcinoma
Choong-won Lee, Byoung Hyuck Kim, Hak Jae Kim
Radiat Oncol J. 2023;41(3):163-171.   Published online 2023 Sep 14     DOI: https://doi.org/10.3857/roj.2023.00437
                        Supplementary      
roj-2023-00437f1.jpgroj-2023-00437f2.jpgroj-2023-00437f3.jpg
172 Application of surface-guided radiation therapy in prostate cancer: comparative analysis of differences with skin marking-guided patient setup
Jaeha Lee, Yeon Joo Kim, Youngmoon Goh, Eunyeong Yang, Ha Un Kim, Si Yeol Song, Young Seok Kim
Radiat Oncol J. 2023;41(3):172-177.   Published online 2023 Sep 18     DOI: https://doi.org/10.3857/roj.2023.00521
                        
roj-2023-00521f1.jpgroj-2023-00521f2.jpgroj-2023-00521f3.jpg
178 Comparison between 1-week and 2-week palliative radiotherapy courses for superior vena cava syndrome
Jongmoo Park, Jeong Eun Lee
Radiat Oncol J. 2023;41(3):178-185.   Published online 2023 Sep 25     DOI: https://doi.org/10.3857/roj.2023.00626
                        Supplementary      
roj-2023-00626f1.jpg
186 Feasibility of artificial intelligence-driven interfractional monitoring of organ changes by mega-voltage computed tomography in intensity-modulated radiotherapy of prostate cancer
Yohan Lee, Hyun Joon Choi, Hyemi Kim, Sunghyun Kim, Mi Sun Kim, Hyejung Cha, Young Ju Eum, Hyosung Cho, Jeong Eun Park, Sei Hwan You
Radiat Oncol J. 2023;41(3):186-198.   Published online 2023 Sep 25     DOI: https://doi.org/10.3857/roj.2023.00444
                        
roj-2023-00444f1.jpgroj-2023-00444f2.jpgroj-2023-00444f3.jpgroj-2023-00444f4.jpgroj-2023-00444f5.jpg
199 Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
Eunyeong Yang, Young Seob Shin, Ji Hyeon Joo, Wonsik Choi, Su Ssan Kim, Eun Kyung Choi, Jaeha Lee, Si Yeol Song
Radiat Oncol J. 2023;41(3):199-208.   Published online 2023 Sep 26     DOI: https://doi.org/10.3857/roj.2023.00591
                        Supplementary      
roj-2023-00591f1.jpgroj-2023-00591f2.jpgroj-2023-00591f3.jpg
209 Developing prompts from large language model for extracting clinical information from pathology and ultrasound reports in breast cancer
Hyeon Seok Choi, Jun Yeong Song, Kyung Hwan Shin, Ji Hyun Chang, Bum-Sup Jang
Radiat Oncol J. 2023;41(3):209-216.   Published online 2023 Sep 21     DOI: https://doi.org/10.3857/roj.2023.00633
                        Supplementary      
roj-2023-00633f1.jpg
Case Report
217 Bleeding metastasis of renal cell cancer to anal canal treated with radiation
Cemal Ulusoy, Sila Guclu Mete, Andrej Nikolovski
Radiat Oncol J. 2023;41(3):217-221.   Published online 2023 Sep 18     DOI: https://doi.org/10.3857/roj.2023.00465
                           Cited By 1
roj-2023-00465f1.jpgroj-2023-00465f2.jpgroj-2023-00465f3.jpgroj-2023-00465f4.jpgt1-roj-2023-00465.png
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.3
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next